Multidimensional Flow Cytometry for Detection of Rare Populations in Hematological Malignancies

Terstappen, 1990, Flow cytometric analysis of human bone marrow. III. Neutrophil maturation, Leukemia, 4, 657 Loken, 1987, Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development, Blood, 70, 1316, 10.1182/blood.V70.5.1316.1316 Loken, 2000, Normal antigen expression in hema-topoiesis: basis for interpreting leukemia phenotypes, 133 Terstappen, 1991, Flow cyto-metric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis, Leukemia, 5, 70 Terstappen, 1990, Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry, Anal Cell Pathol, 2, 229 Terstappen, 1992, Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoi-etic progenitor cells, Leukemia, 6, 993 Hurwitz, 1988, Asynchronous antigen expression in B lineage acute lymphoblastic leukemia, Blood, 72, 299, 10.1182/blood.V72.1.299.299 Sievers, 2003, Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia, Blood, 101, 3398, 10.1182/blood-2002-10-3064 Campana, 2004, Minimal residual disease studies by f low cytometr y in acute leukemia, Act a Haematol, 112, 8, 10.1159/000077554 San Miguel, 2001, Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification, Blood, 98, 1746, 10.1182/blood.V98.6.1746 Venditti, 2000, Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia, Blood, 96, 3948, 10.1182/blood.V96.12.3948 Coustan-Smith, 1998, Immunological detection of minimal residual disease in children with acute lymphoblastic leukemia, Lancet, 351, 550, 10.1016/S0140-6736(97)10295-1 Farahat, 1998, Detection of minimal residual disease in B-lineage acute lymphoblastic leukemia by quantitative flow cytometry, Br J Haematol, 101, 158, 10.1046/j.1365-2141.1998.00675.x Coustan-Smith, 2002, Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia, Blood, 100, 52, 10.1182/blood-2002-01-0006 Stelzer, 1993, CD45 gating for routine flow cytometric analysis of human bone marrow specimens, Ann NY Acad Sci, 677, 265, 10.1111/j.1749-6632.1993.tb38783.x Sievers, 1996, Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry, J Natl Cancer Inst, 88, 1483, 10.1093/jnci/88.20.1483 Borowitz, 1993, Immu-nophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis, Am J Clin Pathol, 100, 534, 10.1093/ajcp/100.5.534 Reading, 1993, Expression of unusual immunophenotype combinations in acute myeloid leukemia, Blood, 81, 3083, 10.1182/blood.V81.11.3083.3083 Greaves, 1986, Lineage promiscuity in hematopoietic differentiation and leukemia, Blood, 67, 1, 10.1182/blood.V67.1.1.1 Wells, 2003, Myeloid and mono-cytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation, Blood, 102, 394, 10.1182/blood-2002-09-2768 Bowen, 1997, Abnormal patterns of expression of CD16 (FcR-III) and CD11b (CR III) antigens by developing neu-trophils in the bone marrow of patients with myelodys-plastic syndrome, Lab Hematol, 3, 292 Stetler-Stevenson, 2001, Diagnostic utility of flow cytometric immunophenotyping in myelo-dysplastic syndrome, Blood, 98, 979, 10.1182/blood.V98.4.979 Maynadie, 2002, Immunophenotypic clustering of myelodysplastic syndromes, Blood, 100, 2349, 10.1182/blood-2002-01-0230